Latest News and Press Releases

WASHINGTON, DC--(Marketwire - March 11, 2010) - Officials from the nation's 28 colleges of veterinary medicine converged on Capitol Hill today to advocate for HR2999, The Veterinary Public Health...

LAS VEGAS, NV--(Marketwire - February 16, 2010) - One of the most diverse representations of veterinary organizations ever assembled completed three days of meetings on Saturday to begin a year-long...

NEW CANAAN, CT--(Marketwire - February 9, 2010) -  Marshall Edwards, Inc. (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics,...

SYDNEY, AUSTRALIA--(Marketwire - February 8, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL) announced that Christopher Naughton had resigned as a member of the Board of Directors effective February 5,...

NEW CANAAN, CT--(Marketwire - January 21, 2010) - The Board of Directors of Marshall Edwards, Inc. today advised that analysis of tumor response data from the OVATURE trial will be performed in the...

SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - December 1, 2009) - Novogen Limited advises that CEO and Managing Director Christopher Naughton will cease his employment with the Company from...

WASHINGTON, DC--(Marketwire - November 25, 2009) - In honor of World AIDS Day, The AIDS Institute (TAI), one of the nation's leading advocacy organizations for support of people with HIV/AIDS and...

PARIS--(Marketwire - October 21, 2009) - EMBARGOED FOR RELEASE UNTIL 2:00pm CEST, or 8:00am USA EST -- Abstract #173886 -- An immunological analysis of a Phase II clinical trial demonstrated that the...

BETHESDA, MD and OSLO, NORWAY and PARIS--(Marketwire - October 19, 2009) - Bionor Immuno announced today at the AIDS Vaccine 2009 conference in Paris, France, that Robert Redfield, MD, Associate...

SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - September 29, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL), a pharmaceutical company specializing in clinical development of oncology drugs, today...